Treatment For Ras-Mutated Mcrc

Treatment for RAS-mutated mCRC

Targeted Oncology

RAS Mutation Testing in mCRC

Dr. Peeters on KRAS/NRAS Mutations in mCRC

Dr. Peeters Discusses KRAS/NRAS Mutations in mCRC

Targeted Oncology

Newly Diagnosed mCRC Treatment Goals

Expanded RAS Mutation Testing in Metastatic Colorectal Cancer

Second-Line Therapy for RAS Wild-Type mCRC

Charles Fuchs, MD: RAS Mutations in Metastatic Colorectal Cancer

Targeted Oncology

BRAF and RAS Mutation Status in Colorectal Cancer

PRIME Trial: RAS Mutations Defined in Colorectal Cancer

How to improve on the outcome in RAS mutant tumors

Survival Differences in KRAS/BRAF Mutations in mCRC

Targeted Oncology

Treatment Options for KRAS-Mutant Unresectable mCRC

Targeted Oncology

Debate 1: First-line Treatment of Metastatic Colorectal Cancer - CALGB 80405

Introduction: Expanded RAS Mutation Testing in Colorectal Cancer

State-of-the-art first-line therapy for mCRC

Upfront Treatment of Unresectable RAS Wild-type Metastatic Colorectal Cancer

Newly Diagnosed mCRC Treatment Goals

Predictive Value of RAS Mutations in Metastatic Colorectal Cancer

Dr. Fakih on RAS mutations in Colon Cancer